Breast cancer outcomes following predictive BRCA testing in Northern Ireland

Gwyneth Hinds, Gareth Irwin, Lesley McFaul, Rachael Stewart, Lyndsey Morton, Kienan I. Savage, Patrick J. Morrison, Stuart A. McIntosh

Research output: Contribution to journalMeeting abstract

6 Citations (Scopus)

Abstract

Objectives: Since 1995, BRCA testing has identified 445 women in Northern Ireland who carry a pathogenic BRCA1/2 mutation, without breast cancer (bca) at testing. This study examined outcomes with reference to management, bca risk, and incidence following positive predictive testing. Methods: Patients were identified from the regional genetics database. Electronic clinical records were used to obtain management and outcome details. Median follow-up was to bca diagnosis, risk-reducing mastectomy (rrm), death, or last follow-up. Results: 169 women had a BRCA1 mutation, and 276 BRCA2. ■ BRCA1 cohort: Median follow-up post-testing was 3 years. 56 Women (33%) had rrm, and 12 are awaiting rrm (total 68, 40%) at a median age of 36 years. 12 Women (7%) developed bca, at a median of 2 years following testing. 4 Women were diagnosed with bcas incidentally at rrm. 7 Patients had bilateral mastectomies following a cancer diagnosis. 1 Woman developed bca following rrm (1.7%). Three deaths were reported: 1 breast cancer (1.7%), 1 ovarian cancer (1.7%), and 1 with no recorded breast/ovarian cancer diagnosis. ■ BRCA2 cohort: Median follow-up post-testing was 6 years. rrm was carried out in 75 women (27%), with 20 awaiting rrm (total 95, 35%); median age: 39 years. 16 Women developed bca (5.8%), at a median of 5 years from testing. 6 Women were diagnosed with cancer incidentally at rrm; 9 women had bilateral mastectomy following diagnosis, and 1 developed bca following rrm (1.3%). Five deaths were reported: 1 bca, 1 ovarian cancer, and 3 with no recorded breast/ovarian cancer diagnosis. Conclusions: The uptake of rrm following predictive BRCA testing in Northern Ireland is comparable with that reported elsewhere. The incidence of bca following rrm is low (<2%) in our cohort, with low breast and ovarian cancer–specific mortality following positive predictive testing.
Original languageEnglish
Article numberP043
Pages (from-to)e298
JournalCurrent Oncology
Volume23
Issue number3
DOIs
Publication statusPublished - Jun 2016
EventSixth International Symposium on Hereditary Breast and Ovarian Cancer - Montreal, Canada
Duration: 10 May 201613 May 2016

Fingerprint Dive into the research topics of 'Breast cancer outcomes following predictive BRCA testing in Northern Ireland'. Together they form a unique fingerprint.

  • Cite this

    Hinds, G., Irwin, G., McFaul, L., Stewart, R., Morton, L., Savage, K. I., Morrison, P. J., & McIntosh, S. A. (2016). Breast cancer outcomes following predictive BRCA testing in Northern Ireland. Current Oncology, 23(3), e298. [P043]. https://doi.org/10.3747/co.23.3327